trending Market Intelligence /marketintelligence/en/news-insights/trending/y3WzL2DJu5oZxseX4XJ1iQ2 content esgSubNav
In This List

Haba Laboratories fiscal Q4 profit falls YOY

Podcast

Street Talk | Episode 105: Banks could see opportunity in fintech's cleansing fire

Blog

The Climate Vulnerability Assessment by APRA: Helping Financial Institutions Address Challenges

Blog

A Sustainability Framework for Customer and Supplier Credit Risk Management

Video

Lithium Import


Haba Laboratories fiscal Q4 profit falls YOY

Haba Laboratories Inc. said its normalized net income for the fiscal fourth quarter ended March 31 came to ¥79.28 per share, a decrease of 11.1% from ¥89.13 per share in the year-earlier period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was ¥311.9 million, a decrease of 11.1% from ¥350.6 million in the prior-year period.

The normalized profit margin declined to 8.0% from 8.8% in the year-earlier period.

Total revenue decreased year over year to ¥3.90 billion from ¥3.96 billion, and total operating expenses totaled ¥3.39 billion, compared with ¥3.40 billion in the prior-year period.

Reported net income declined 64.4% on an annual basis to ¥217.0 million, or ¥55.16 per share, from ¥610.0 million, or ¥155.07 per share.

For the year, the company's normalized net income totaled ¥38.61 per share, a decline of 79.9% from ¥191.77 per share in the prior year.

Normalized net income was ¥151.9 million, a decline of 79.9% from ¥754.4 million in the prior year.

Full-year total revenue decreased on an annual basis to ¥13.18 billion from ¥13.79 billion, and total operating expenses grew on an annual basis to ¥12.90 billion from ¥12.53 billion.

The company said reported net income fell 95.2% on an annual basis to ¥44.0 million, or ¥11.19 per share, in the full year, from ¥916.0 million, or ¥232.86 per share.

As of June 22, US$1 was equivalent to ¥123.23.